ACHIEVE LIFE SCIENCES, INC.
1040 West Georgia Street, Suite 1030
Vancouver, British Columbia, Canada V6E 4H1
August 5, 2019
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ada D. Sarmento
Re: | Achieve Life Sciences, Inc. Registration Statement on Form S-1 (File No. 333-232817) originally filed July 25, 2019, as amended | |
Requested Date: August 7, 2019 | ||
Requested Time: 4:00 PM Eastern Time |
Ladies and Gentlemen:
Achieve Life Sciences, Inc. (the Registrant) hereby requests that the Securities and Exchange Commission (the Commission) take appropriate action to make the above-captioned Registration Statement on Form S-1 effective at the Requested Date and Requested Time set forth above or as soon thereafter as practicable.
The Registrant hereby authorizes Alan Smith or Amanda Rose, both of whom are attorneys with the Registrants outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Ms. Rose at (206) 389-4553, or in her absence, Mr. Smith at (206) 389-4530.
Sincerely, | ||
ACHIEVE LIFE SCIENCES, INC. | ||
By: | /s/ John Bencich | |
John Bencich | ||
Chief Financial Officer |